03.14.2022
Emergent Announces Additions to Leadership Team
Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.
03.14.2022
Emergent is pleased to announce the addition of two senior leaders to its CDMO and Quality & Compliance organizations.
03.11.2022
Dino Muzzin, senior vice president of manufacturing operations at Emergent BioSolutions recently shared his insights with Pharma...
07.23.2021
With the expansion of our viral drug product manufacturing facility in Rockville, Maryland well underway, we have begun...
05.12.2021
Our drug product manufacturing facility in Rockville, Maryland is undergoing an expansion that will soon house a...
02.13.2021
Emergent has entered into a new CDMO agreement with Providence Therapeutics to provide fill/finish drug product manufacturing...
01.25.2021
GAITHERSBURG, MD. and BURLINGAME, CA. – Jan. 25, 2021 — Emergent BioSolutions Inc. (NYSE:EBS) (Emergent) and Humanigen, Inc. ...
10.01.2020
Emergent BioSolutions, a Wells Fargo Corporate & Investment Banking customer since 2011, helps governments respond to health...
09.01.2020
“Emergent has a long, successful history of working with the US government to develop, manufacture, and deliver safe and...
07.07.2020
Read the latest news coverage of Emergent's insights and involvement in the fight against COVID-19. Last Updated: Thursday,...
06.02.2020
Emergent BioSolutions recently announced that it has been issued a task order under an existing contract with the Biomedical...
04.14.2022
Emergent recently had the pleasure of participating in the Molecule to Market Podcast hosted by Ramen Sehgal from from ra...
07.05.2021
There has been a steady increase in demand for lyophilized products in recent years. Due in large part to biologic drug...
05.27.2021
“The Vanrx SA25 Aseptic Filling Workcell is a state-of-the-art machine, providing our clients with a high level of sterility...
03.12.2021
In a recent Pharmaceutical Technology article, Emergent experts provide their insights on selection of technologies for vaccine...
12.01.2020
Excerpt taken from BioPharm International October 2020 Regulatory Sourcebook article titled: GMPs Guide COVID-19 Vaccine...
11.30.2020
Jee Look, senior director of drug product development for Emergent BioSolutions recently contributed to an article in ...
10.31.2020
With ongoing advances in science and technology, the cell and gene therapy pipeline has grown especially robust over the past...
09.21.2020
Syed T. Husain, senior vice president and CDMO business unit head at Emergent BioSolutions recently contributed to an editorial...
07.29.2020
In a recent article with BioProcess International, Syed T. Husain, senior vice president & CDMO business unit head at Emergent...
09.14.2021
07.06.2020
06.18.2020
06.01.2020
04.01.2020
03.19.2020
GAITHERSBURG, Md., March 18, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered...
03.19.2020
GAITHERSBURG, Md., March 10, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) announced today that it has entered...
12.11.2021
Our viral drug product manufacturing facility in Rockville, MD is home to our INTEGRA® high-speed bulk filling line, with fully...
06.24.2021
Our state-of-the-art Vanrx® SA25 Aseptic Filling Workcell can be deployed to support your clinical or commercial drug product...
04.14.2021
Watch our latest webinar on the topic of aseptic fill/finish and isolator-based technology for pre-sterilized syringes,...
04.27.2020
Watch our latest webinar on the topic of how drug developers can maximize capacity, capabilities and expertise for pandemic...
04.17.2020
What are innovators doing to speed up the path to treating and preventing COVID-19?
The novel coronavirus has quickly taken...
03.14.2022
Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support...
11.19.2021
Regardless of where a drug candidate is in the development pipeline, performing a technology transfer (tech transfer) presents...
08.30.2021
Successful downstream processing provides isolation of the molecule of interest from extraneous constituents before formulation,...
08.19.2021
Mitigating risk is a key consideration for biopharmaceutical companies when planning their clinical trial material and/or drug...
01.13.2022
From analytical development to drug substance and drug product process development and scale-up, we can help advance your...